Gastric cancer is one of the most common cancers and remains the second leading cause of cancer-related deaths worldwide. Despite ongoing research and recent progress, the prognosis for most patients with gastric cancer remains poor, with 5-year survival following surgical resection and perioperative chemotherapy or postoperative chemoradiation ranges from 30 to 35%. This book, written by experts in the field, provides rapid access to information that will improve general knowledge about gastric cancer and help in improving care of patients. Topics covered include the epidemiology of the disease, conventional therapies such as surgery and chemoradiation, novel targeted therapies and an overview of published guidelines for the management of gastric cancer.